Patents by Inventor Edward L. Morgan

Edward L. Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to human C5a receptor
    Patent number: 5480974
    Abstract: A peptide-specific monoclonal antibody derived from an immunogenic peptide from the extracellular hydrophilic region of the human C5 a receptor (C5aR) is useful for blocking C5a from binding to C5aR.
    Type: Grant
    Filed: June 18, 1993
    Date of Patent: January 2, 1996
    Assignee: The Scripps Research Institute
    Inventors: Edward L. Morgan, Julia A. Ember, Tony E. Hugli
  • Lymphocyte-activating polypeptides
    Patent number: 4683221
    Abstract: A lymphocyte-activating polypeptide, a composition containing the polypeptide and a method for using the composition are disclosed. The polypeptide contains a sequence of 4 to about 11 residues and corresponds in sequence to the formula:(B).sub.b -Leu-Pro-Pro-Ser-(Y).sub.y.
    Type: Grant
    Filed: January 9, 1986
    Date of Patent: July 28, 1987
    Assignee: Scripps Clinic and Research Foundation
    Inventors: William O. Weigle, Monte O. Hobbs, Edward L. Morgan, Marilyn L. Thoman, Richard A. Houghten
  • Blow molded tubing with special holes and method of making same
    Patent number: 4655986
    Abstract: A method of making blow-molded perforated tubing and the tubing made by said method is provided. In the method of the invention, hollow-walled protuberances are blow molded into the side of the tubing as the tubing is formed and perforations are formed by cutting the hollow-walled protuberances.
    Type: Grant
    Filed: December 3, 1984
    Date of Patent: April 7, 1987
    Assignee: Dayco Products, Inc.
    Inventors: Liggett A. Cothran, Edward L. Morgan, Robert E. Stevens, Homer N. Holden, R. Neal Ensley
  • Immune modulator peptides
    Patent number: 4415493
    Abstract: A class of 23 or 24 amino acid peptides available by chemical synthesis or by enzymatic and chemical cleavage of IgG is described. The compounds are useful in modulating the immune response.
    Type: Grant
    Filed: May 11, 1982
    Date of Patent: November 15, 1983
    Assignee: Scripps Clinic and Research Foundation
    Inventors: William O. Weigle, Edward L. Morgan